Is ESG-ness the vaccine?

November 27, 2021 Siddhant Goyal

Date of Publication: Oct 21, 2021

Author: Fabio Pizzutilo

Summary:

In an attempt to foster debate on whether firms’s commitment to ESG policies affects stocks risk-adjusted performance, we analysed the blue-chips of the European countries most affected by COVID-19. We found statistical evidence that companies that follow high ESG standards outperformed low ESG-ranked firms during Phase 1 of COVID-19. In particular, the dampening effect on the downside stock market movement was more evident during the first part of Phase 1 characterized by the sudden crash of stock prices.

Link to Full Reading:

https://www.tandfonline.com/doi/full/10.1080/13504851.2021.1994124